CAS number: 514-36-3

General information about the Fludrocortisone Acetate active pharmaceutical ingredient

Fludrocortisone Acetate as active pharmaceutical ingredient (API) is a synthetic mineralocorticoid that inhibits endogenous adrenal cortical secretion. Fludrocortisone Acetate is used to treat conditions in which the body does not produce enough of its own steroids, such as Addison’s disease, and salt-losing adrenogenital syndrome. Fludrocortisone Acetate can be found in the form of oral tablets.

Axplora manufactures Fludrocortisone Acetate API

Fludrocortisone Acetate API is manufactured in cGMP by Axplora via chemical synthesis from early stage starting material. Fludrocortisone Acetate API is produced by Farmabios, our EUGMP, USFDA and PMDA approved manufacturing site with legal seat in Gropello Cairoli, Italy. Farmabios’ expertise is to make and handle with steroids, niche hormones, and highly potent active pharmaceutical ingredient (HPAPI), including cytotoxic drugs. Fludrocortisone Acetate API is commercially available as micronized grade specifically designed around various formulation requirements.Tailor-made packaging solutions are available upon request. Feel free to contact us if you need any additional information about Fludrocortisone Acetate API.
  • Therapeutic area Adrenocortical
  • Monograph PH.EUR.
  • Available grade Micronized
  • Regulatory documentation US DMF
  • Produced in GRO